Blackstone Commits Up to $1.5 Billion to Pfizer's Next-Generation Weight-Loss Drug Development
Blackstone Life Sciences has agreed to provide up to $1.5 billion to support Pfizer's development of berobenatide, an investigational monthly…
Blackstone Life Sciences has agreed to provide up to $1.5 billion to support Pfizer's development of berobenatide, an investigational monthly…
Claims linking COVID-19 vaccines to heart attacks have spread widely, especially after sudden deaths among younger Indians. Indian studies have…
Roche’s agreement with Atavistik Bio targets cardiovascular, kidney and metabolic disease, extending Big Pharma’s push to source novel drug platforms…
Novo Nordisk has licensed Nanexa’s PharmaShell platform in a deal worth up to €1.165 billion, targeting monthly or potentially quarterly…
Eli Lilly and China’s InnoCare have formed a research and licensing partnership covering up to five targets, adding to a…
Read next